There is controversy over CD4 + T cells’ role in anti-cancer immunity, although most studies suggest that tumor-infiltrating CD4 + T cells may serve as a prognostic marker for Treg, a crucial mediator of tumor immunosuppression [89]. The gene discussed is CD4; the disease is cancer.